NLS Pharmaceutics (NLSP) Short Interest Ratio & Short Volume → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free NLSP Stock Alerts $0.14 -0.03 (-17.54%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NLS Pharmaceutics Short Interest DataCurrent Short Interest45,400 sharesPrevious Short Interest16,100 sharesChange Vs. Previous Month+181.99%Dollar Volume Sold Short$6,628.40Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Float Size25,860,000 sharesShort Percent of Float0.18%Today's Trading Volume1,151,375 sharesAverage Trading Volume1,256,398 sharesToday's Volume Vs. Average92% Short Selling NLS Pharmaceutics ? Sign up to receive the latest short interest report for NLS Pharmaceutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNLSP Short Interest Over TimeNLSP Days to Cover Over TimeNLSP Percentage of Float Shorted Over Time Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. NLS Pharmaceutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202445,400 shares $6,628.40 +182.0%0.2%0.1 $0.15 4/30/202416,100 shares $2,249.17 -78.6%0.1%0 $0.14 4/15/202475,100 shares $10,626.65 -77.6%0.3%0.1 $0.14 3/31/2024335,800 shares $60,444.00 +854.0%1.5%0.6 $0.18 3/15/202435,200 shares $10,876.80 -43.0%0.2%0.1 $0.31 2/29/202461,800 shares $23,904.24 -22.4%0.3%0.8 $0.39 Get the Latest News and Ratings for NLSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202479,600 shares $35,820.00 -15.4%0.3%0.2 $0.45 1/31/202494,100 shares $43,286.00 -22.4%0.4%0.2 $0.46 1/15/2024121,200 shares $63,024.00 -19.7%0.5%0.2 $0.52 12/31/2023150,900 shares $89,015.91 +32.5%0.7%0.3 $0.59 12/15/2023113,900 shares $54,672.00 -15.0%0.5%0.2 $0.48 11/30/2023134,000 shares $58,785.80 +29.0%0.7%0.2 $0.44 11/15/2023103,900 shares $50,713.59 -37.2%0.5%0.7 $0.49 10/31/2023165,400 shares $109,164.00 -24.0%0.8%1.6 $0.66 10/15/2023217,700 shares $182,693.84 +40.2%1.1%1.8 $0.84 9/30/2023155,300 shares $108,710.00 -2.1%0.8%1.7 $0.70 9/15/2023158,600 shares $131,526.98 +33.3%0.8%0.9 $0.83 8/31/2023119,000 shares $121,380.00 +38.7%0.6%0.7 $1.02 8/15/202385,800 shares $70,347.42 -23.5%0.4%0.6 $0.82 7/31/2023112,100 shares $104,006.38 +95.3%0.6%0.8 $0.93 7/15/202357,400 shares $51,591.12 +48.7%0.3%0.5 $0.90 6/30/202338,600 shares $42,460.00 -43.4%0.2%0.3 $1.10 6/15/202368,200 shares $66,154.00 -31.7%0.3%1.6 $0.97 5/31/202399,900 shares $102,897.00 -8.9%0.5%2.4 $1.03 5/15/2023109,600 shares $117,820.00 -6.4%0.5%2.2 $1.08 4/30/2023117,100 shares $155,743.00 -0.4%0.5%2.3 $1.33 4/15/2023117,600 shares $183,456.00 -7.2%0.6%2.3 $1.56 3/31/2023126,700 shares $192,584.00 +44.3%0.6%1.8 $1.52 3/15/202387,800 shares $130,822.00 -38.8%0.4%1 $1.49 2/28/2023143,500 shares $205,205.00 +5.6%0.7%1.5 $1.43 2/15/2023135,900 shares $186,183.00 +13.4%0.7%1.1 $1.37 1/31/2023119,800 shares $155,740.00 -22.3%0.6%0.8 $1.30 1/15/2023154,100 shares $265,052.00 -23.2%0.7%0.4 $1.72 12/30/2022200,700 shares $258,903.00 +32.2%0.9%0.5 $1.29 12/15/2022151,800 shares $157,872.00 +26.6%0.7%0.3 $1.04 11/30/2022119,900 shares $99,517.00 -23.3%1.0%0.2 $0.83 11/15/2022156,300 shares $78,915.87 +63.0%1.3%0.3 $0.50 10/31/202295,900 shares $50,107.75 +15.7%0.8%0.1 $0.52 10/15/202282,900 shares $43,108.00 -57.2%0.7%0.2 $0.52 9/30/2022193,500 shares $119,970.00 -27.6%1.4%0.4 $0.62Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 9/15/2022267,100 shares $226,500.80 +80.6%1.9%0.6 $0.85 8/31/2022147,900 shares $73,195.71 -27.5%1.1%0.4 $0.49 8/15/2022203,900 shares $100,930.50 -6.0%1.5%0.6 $0.50 7/31/2022216,900 shares $80,209.62 +111.8%1.6%0.8 $0.37 7/15/2022102,400 shares $65,382.40 -28.3%0.8%0.5 $0.64 6/30/2022142,800 shares $83,852.16 +35.4%1.1%2.4 $0.59 6/15/2022105,500 shares $62,034.00 -21.6%0.8%1.9 $0.59 5/31/2022134,500 shares $91,460.00 +40.8%1.0%1.4 $0.68 5/15/202295,500 shares $55,390.00 -13.7%0.7%0.8 $0.58 4/30/2022110,600 shares $94,795.26 -6.2%0.9%0.7 $0.86 4/15/2022117,900 shares $122,616.00 -26.1%1.0%0.7 $1.04 3/31/2022159,600 shares $225,036.00 +39.3%2.0%0.6 $1.41 3/15/2022114,600 shares $201,696.00 -19.9%1.4%0 $1.76 2/28/2022143,100 shares $170,289.00 +246.5%1.8%0 $1.19 2/15/202241,300 shares $44,191.00 -6.1%0.7%0 $1.07 1/31/202244,000 shares $39,600.00 -85.6%0.7%0 $0.90 1/15/2022305,300 shares $332,777.00 +172.6%5.1%0.1 $1.09 12/31/2021112,000 shares $124,320.00 -17.3%1.9%0 $1.11 12/15/2021135,400 shares $167,706.44 +56.7%2.3%0.2 $1.24 11/30/202186,400 shares $175,392.00 +8.3%1.4%0.1 $2.03 11/15/202179,800 shares $173,166.00 -13.8%1.3%1.2 $2.17 10/29/202192,600 shares $200,016.00 +51.6%1.5%0.3 $2.16 10/15/202161,100 shares $147,251.00 +25.0%1.0%0.2 $2.41 9/30/202148,900 shares $122,250.00 -55.2%0.8%0.1 $2.50 9/15/2021109,200 shares $287,196.00 -19.5%1.9%0.2 $2.63 8/31/2021135,600 shares $334,932.00 +227.5%2.4%0.3 $2.47 8/13/202141,400 shares $97,704.00 No Change0.7%0.1 $2.36 NLSP Short Interest - Frequently Asked Questions What is NLS Pharmaceutics' current short interest? Short interest is the volume of NLS Pharmaceutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 45,400 shares of NLSP short. 0.18% of NLS Pharmaceutics' shares are currently sold short. Learn More on NLS Pharmaceutics' current short interest. What is a good short interest percentage for NLS Pharmaceutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of NLS Pharmaceutics' floating shares are currently sold short. Is NLS Pharmaceutics' short interest increasing or decreasing? NLS Pharmaceutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 45,400 shares, an increase of 182.0% from the previous total of 16,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NLS Pharmaceutics' float size? NLS Pharmaceutics currently has issued a total of 0 shares. Some of NLS Pharmaceutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NLS Pharmaceutics currently has a public float of 25,860,000 shares. How does NLS Pharmaceutics' short interest compare to its competitors? 0.18% of NLS Pharmaceutics' shares are currently sold short. Here is how the short interest of companies compare to NLS Pharmaceutics: LAVA Therapeutics (0.84%), Mainz Biomed (1.75%), Pharvaris (0.66%), Procaps Group S.A. (0.07%), Qilian International Holding Group Limited (0.68%), Aditxt, Inc. (8.85%), Exicure, Inc. (1.68%), Palisade Bio, Inc. (3.83%), Plus Therapeutics, Inc. (2.89%), Trevi Therapeutics, Inc. (1.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short NLS Pharmaceutics stock? Short selling NLSP is an investing strategy that aims to generate trading profit from NLS Pharmaceutics as its price is falling. NLSP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NLS Pharmaceutics? A short squeeze for NLS Pharmaceutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NLSP, which in turn drives the price of the stock up even further. How often is NLS Pharmaceutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLSP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LVTX Short Squeeze MYNZ Short Squeeze PHVS Short Squeeze PROC Short Squeeze QLI Short Squeeze ADTX Short Squeeze XCUR Short Squeeze PALI Short Squeeze PSTV Short Squeeze TRVI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NLSP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.